Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected Patients
Public ClinicalTrials.gov record NCT00002229. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IV, Non-Comparative Study to Evaluate FORTOVASE (Saquinavir) Soft Gel Capsule (SGC) TID Regimen in Combination With Two NRTI's in HIV-1 Infected Women and Men
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to see if it is safe and effective to give saquinavir (as a soft gel capsule taken by mouth) along with 2 other anti-HIV drugs to HIV-infected patients.
Study identification
- NCT ID
- NCT00002229
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 16 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 23, 2005
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ASC Inc | Hobson City | Alabama | 36201 | — |
| Dean Martin | Phoenix | Arizona | 85006 | — |
| Wilbert Jordan | Paramount | California | 90723 | — |
| Whitman Walker Clinic | Washington D.C. | District of Columbia | 20009 | — |
| Duval County Health Department | Jacksonville | Florida | 32206 | — |
| Ctr for Quality Care | Tampa | Florida | 33609 | — |
| NTouch Research Corp | Decatur | Georgia | 30033 | — |
| Univ of Illinois Hosp at Chicago | Chicago | Illinois | 60612 | — |
| Univ of Kentucky | Lexington | Kentucky | 40536 | — |
| C100 HIV Outpatient Program | New Orleans | Louisiana | 70112 | — |
| NJ CRI | Newark | New Jersey | 07103 | — |
| UMDNJ / Dept of Ob/Gyn | Newark | New Jersey | 07103 | — |
| SUNY Health Sciences Ctr | Brooklyn | New York | 11203 | — |
| Brookdale Univ Med Ctr | Brooklyn | New York | 11212 | — |
| Mt Vernon Hosp | Mount Vernon | New York | 10550 | — |
| Mount Sinai Med Ctr | New York | New York | 100296574 | — |
| Harlem Hosp Infectious Disease | New York | New York | 10037 | — |
| Mem Hosp of Rhode Island | Pawtucket | Rhode Island | 02860 | — |
| Diversified Med Practices, PA | Houston | Texas | 77027 | — |
| Univ of Virginia Health Sciences Ctr | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002229, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2005 · Synced Sep 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00002229 live on ClinicalTrials.gov.